促销时间表 Axcella Health Inc.
先进的时间表
简单图表
关于公司
Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. 更多详情| EBITDA | -0.0328 |
|---|---|
| EV/EBITDA | 1.67 |
| IPO date | 2019-05-09 |
| ISIN | US05454B1052 |
| Industry | Biotechnology |
| P/BV | 27.05 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.axcellahealth.com |
| Цена ао | 0.4009 |
| 每日价格变化: | 0% (0.4009) |
|---|---|
| 每周价格变化: | 0% (0.4009) |
| 每月价格变化: | 0% (0.4009) |
| 3个月内价格变化: | 0% (0.4009) |
| 六个月内的价格变化: | 0% (0.4009) |
| 每年价格变化: | 0% (0.4009) |
| 3年内价格变化: | -84.09% (2.52) |
| 5年内价格变化: | -88.31% (3.43) |
| 10年价格变化: | 0% (0.4009) |
| 年初以来价格变化: | 0% (0.4009) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Flagship Pioneering Inc. | 1170059 | 39.69 |
| Harbourvest Partners, LLC | 248317 | 8.42 |
| Schonfeld Strategic Advisors LLC | 100600 | 3.41 |
| FMR, LLC | 66455 | 2.25 |
| Vanguard Group Inc | 32034 | 1.09 |
| Geode Capital Management, LLC | 11022 | 0.37 |
| Blackrock Inc. | 9903 | 0.34 |
| Tower Research Capital LLC (TRC) | 1225 | 0.04 |
| JP Morgan Chase & Company | 1073 | 0.04 |
| Morgan Stanley | 1004 | 0.03 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Dr. Alison D. Schecter M.D. | Pres of Strategy & Operations | 525.53k | 1964 (61 年) |
| Mr. David R. Epstein B.Sc., M.B.A. | Consultant | 228.34k | 1962 (63 年) |
| Mr. Dan Kirby | Sr. VP of Strategic Operations | N/A | |
| Mr. William R. Hinshaw Jr. | Pres, CEO & Director | 1969 (56 年) | |
| Mr. Laurent Chardonnet | Consultant | 1965 (60 年) | |
| Mr. Robert W. Crane | Sr. VP & CFO | 1959 (66 年) | |
| Dr. Paul Fehlner J.D., Ph.D. | Sr. VP, Chief Legal Officer & Corp. Sec. | 1964 (61 年) | |
| Ms. Virginia R. Dean | Sr. VP & Chief People Officer | 1966 (59 年) | |
| Dr. Larry Bell | Global Head of Regulatory Affairs & Pharmacovigilance and Sr. VP | ||
| Dr. Margaret James Koziel M.D. | Sr. VP & Chief Medical Officer | 1960 (65 年) |
地址: United States, Cambridge. MA, 840 Memorial Drive - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.axcellahealth.com
网站: https://www.axcellahealth.com
